Literature DB >> 16059479

Pregabalin: insights from randomized trials.

Bassel W Abou-Khalil.   

Abstract

Year:  2004        PMID： 16059479      PMCID： PMC1176351          DOI： 10.1111/j.1535-7597.2004.44008.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.

Authors:  R H Dworkin; A E Corbin; J P Young; U Sharma; L LaMoreaux; H Bockbrader; E A Garofalo; R M Poole
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

Authors:  Atul C Pande; Jerri G Crockatt; Douglas E Feltner; Carol A Janney; Ward T Smith; Richard Weisler; Peter D Londborg; Robert J Bielski; Dan L Zimbroff; Jonathan R T Davidson; Maria Liu-Dumaw
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

3.  Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5.

Authors: 
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures.

Authors:  J A French; A R Kugler; J L Robbins; L E Knapp; E A Garofalo
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

5.  Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.

Authors:  Santiago Arroyo; Henning Anhut; Alan R Kugler; Caroline M Lee; Lloyd E Knapp; Elizabeth A Garofalo; Silke Messmer
Journal:  Epilepsia       Date:  2004-01       Impact factor: 5.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.